Study Evaluating the Long-Term Safety of Desvenlafaxine Succinate Sustained-Release (DVS SR) in Subjects With Pain Associated With Diabetic Peripheral Neuropathy
Clinical trial NCT01050218 · TERMINATED
Trial details
- NCT number
- NCT01050218
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-01
- Primary completion
- 2009-01-01
- Enrollment
- 237
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.